Resuscitation, Hemodynamic Shock & ACLS
Undifferentiated Hypotension, Shock Profiles, Cardiac Arrest, and Vasoactive Resuscitation
The initial stabilization of the critically ill patient with undifferentiated hypotension requires rapid identification of the underlying shock etiology through targeted physical examination, invasive hemodynamics or point-of-care ultrasound (RUSH exam), and aggressive restoration of tissue perfusion. Board questions demand mastery of the four primary shock classes, ACLS dysrhythmia pathways, and appropriate selection of inotropes and vasopressors.
1.1 Pathophysiologic Classification of Shock & Hemodynamic Profiles
Shock is defined at the cellular level as acute circulatory failure leading to inadequate tissue perfusion, resulting in cellular hypoxia, anaerobic metabolism, and systemic lactic acidosis. Clinically, shock is categorized into four distinct pathophysiological phenotypes: hypovolemic, cardiogenic, obstructive, and distributive. In hypovolemic shock (hemorrhage, severe dehydration, third-spacing), decreased circulating plasma volume causes marked reductions in cardiac output (CO) and pulmonary capillary wedge pressure (PCWP/preload), triggering compensatory peripheral vasoconstriction that manifests as markedly elevated systemic vascular resistance (SVR). Patients present with cold, clammy extremities, collapsed jugular veins, and tachycardia.
Cardiogenic shock occurs due to primary pump failure, most frequently secondary to massive acute myocardial infarction, severe acute valvular regurgitation (e.g., papillary muscle rupture), or decompensated cardiomyopathy. Hemodynamically, cardiac contractility is profoundly impaired, leading to severely decreased cardiac output, elevated ventricular end-diastolic pressures (high PCWP), and compensatory elevated SVR. On physical exam, patients present with pulmonary edema (crackles), elevated jugular venous distention (JVD), an S3 gallop, and cool extremities. First-line medical support includes inotropes (dobutamine, milrinone) to enhance forward flow, vasopressors (norepinephrine) if mean arterial pressure (MAP) is < 65 mmHg, and prompt mechanical circulatory support (intra-aortic balloon pump [IABP] or Impella) with emergency catheterization.
Obstructive shock is characterized by physical impedance to cardiac chamber filling or right ventricular outflow. The classic etiologies include massive pulmonary embolism (RV strain, elevated CVP, low PCWP, low CO), cardiac tamponade (impaired diastolic filling of all chambers with equalization of diastolic pressures and pulsus paradoxus > 10 mmHg), and tension pneumothorax (mediastinal shift kinking the inferior vena cava). In contrast, distributive shock—predominantly septic shock, anaphylaxis, and neurogenic shock—is marked by severe pathological systemic vasodilation. Here, SVR is profoundly decreased, and in early 'warm shock', cardiac output is elevated or normal with warm, hyperemic extremities and bounding pulses. Neurogenic shock represents a unique distributive state caused by high cervical or thoracic spinal cord transection (above T6), disrupting descending sympathetic tone and resulting in the classic hemodynamic triad of hypotension, relative bradycardia, and warm dry skin without compensatory vasoconstriction.
Sepsis-3 Resuscitation & Vasoactive Pressor Escalation Matrix
Clinical Matrix| Phase / Agent | Clinical Mechanism | Hemodynamic Target | High-Yield Board Caveat |
|---|---|---|---|
| Crystalloid Bolus (Hour-1) | Balanced crystalloid 30 mL/kg within 3 hr | MAP ≥ 65 mmHg; lactate clearance | Avoid 0.9% normal saline boluses in large volumes due to hyperchloremic metabolic acidosis. |
| Norepinephrine (Levophed) | Potent alpha-1 vasoconstriction > beta-1 inotropy | First-line vasopressor of choice in septic & cardiogenic shock | Titrate rapidly via central venous access; maintains renal/splanchnic perfusion. |
| Vasopressin (0.03 units/min) | V1 vascular smooth muscle constriction (non-adrenergic) | Second-line catecholamine-sparing agent | Do NOT titrate; fixed dose added when norepinephrine requirements exceed 0.25 mcg/kg/min. |
| Epinephrine (Adrenaline) | Potent beta-1, beta-2 (low dose) and alpha-1 (high dose) | First-line in anaphylactic shock; 2nd/3rd line in refractory septic shock | Produces transient hyperlactatemia via aerobic skeletal muscle glycolysis (type B hyperlactatemia). |
| Dobutamine | Beta-1 inotrope > beta-2 vasodilator | Added in persistent hypoperfusion despite adequate volume and MAP | Contraindicated as monotherapy in hypotension; causes reflex vasodilation. |
Cardiopulmonary Autonomics & Thoracic Inlet Release
1.2 Advanced Cardiac Life Support (ACLS) & Rapid Sequence Intubation (RSI)
In cardiac arrest, rhythm analysis partitions cases into shockable rhythms (Ventricular Fibrillation [VF] and Pulseless Ventricular Tachycardia [pVT]) and non-shockable rhythms (Pulseless Electrical Activity [PEA] and Asystole). For VF/pVT, immediate defibrillation (unsynchronized high-energy shock) is the single most critical determinant of survival, followed immediately by 2 minutes of uninterrupted, high-quality chest compressions (100–120 bpm, 2–2.4 inches depth, allowing complete chest recoil). Epinephrine 1 mg IV/IO is administered every 3 to 5 minutes, beginning after the second defibrillation cycle. Amiodarone (300 mg bolus, followed by a 150 mg second dose) or Lidocaine (1–1.5 mg/kg) is administered after the third shock for refractory VF/pVT.
For non-shockable rhythms (PEA/Asystole), defibrillation is strictly contraindicated. CPR and immediate administration of Epinephrine 1 mg IV/IO must occur without delay. The clinician must relentlessly search for and treat reversible underlying causes using the classic 5 H's and 5 T's: Hypovolemia, Hypoxia, Hydrogen ion (acidosis), Hypo-/Hyperkalemia, Hypothermia; Tension pneumothorax, Tamponade (cardiac), Toxins, Thrombosis (pulmonary PE), and Thrombosis (coronary ACS). Return of spontaneous circulation (ROSC) is evidenced by an abrupt, sustained increase in end-tidal CO2 (PETCO2 ≥ 40 mmHg) or arterial pressure waveforms.
Emergency airway management in the resuscitation bay hinges upon Rapid Sequence Intubation (RSI)—the virtually simultaneous administration of a potent induction agent and a neuromuscular blocking agent to facilitate endotracheal tube placement while minimizing aspiration risk. Etomidate (0.3 mg/kg) is widely favored for its exceptional hemodynamic neutrality; however, its transient suppression of 11-beta-hydroxylase must be considered in severe septic shock. Ketamine (1.5–2 mg/kg) is ideal for hypotensive trauma and status asthmaticus due to its catecholamine-releasing sympathomimetic properties and intrinsic bronchodilation. Succinylcholine (1.5 mg/kg) is a depolarizing paralytic with rapid 45-second onset, but is strictly contraindicated in hyperkalemia, severe crush injuries > 48 hours old, extensive burns > 48 hours old, chronic denervating diseases (ALS, MS), and malignant hyperthermia susceptibility. In such settings, high-dose Rocuronium (1.2 mg/kg) is the paralytic of choice, which can be rapidly reversed with Sugammadex if needed.
Board Trap — Succinylcholine Hyperkalemia Lethality
Chapter 1 Quick-Check Self-Assessment
Test your clinical reasoning before moving to the next chapter